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Background: Transcatheter aortic valve implantation (TAVI) is being evaluated for patients (pts) with severe aortic stenosis (AS) who are 
considered high risk surgical candidates. Most TAVI using the Edwards SAPIEN valve are done under general anaesthesia, which carries the risk of 
respiratory complications. We aimed to examine the feasibility and safety of TAVI under conscious sedation (CS)
Methods: The analysis included 48 consecutive pts undergoing TAVI guided by transesophageal echocardiography using the Edwards SAPIEN valve 
via the trans femoral approach. CS was given by anesthesiologist in one of two protocol regimens: Ketamine with Propofol or Dexmetetomidine. The 
crossover rate to general anesthesia and the clinical outcome related to the anesthesia were compared
Results: Edwards SAPIEN implantation was performed in 34 (70.8%) pts with CS, and 14 (29.1%) pts with general anaesthesia. The baseline 
characteristics and results are summarized in Table. Of the pts with CS 4(11.7%) converted to general anaesthesia with intubation. The indications 
for crossover were hemodynamic compromise with shock after balloon valvuloplasty or valve deployment (n=3) and when high access retroperitoneal 
approach was required (n=1)
Conclusion: TAVI can be performed in the majority of the cases with controlled CS avoiding the necessity of general anaesthesia with low 
conversion rate to general anaesthesia. This leads to shorter procedure time, and may shorten the stay in the intensive care unit and in hospital. 
Conscious sedation
N= 34
General anesthesia
N= 14
P
Mean age (years) 82.7.1±5.1 84.4±7.8 0.4
Female (%) 19(55.8) 4(28.5) 0.3
STS 11.6±3.5 10.9±4.3 0.5
Logistic EuroSCORE 39.1±21.4 25.9±15.1 0.02
Ejection fraction (%) 53.1±16.0 53.2±15.1 0.9
COPD (%) 5 (14.7) 1 (7.1) 0.9
Aortic valve area (cm2) 0.63±0.13 0.61±0.11 0.6
Surgical access (%) 21 (61.7) 14 (100) <0.001
26-mm valve (%)
23-mm valve
11 (23.3)
23 (67.6)
7 (50)
7 (50)
0.25
Procedure duration (minutes)
136.6±56.3
142.5 [88.7-180.0]
213.7±93.0
190 [157.7-251.2]
0.01
ICU stay (days)
61.3±58.3
30 [23-72]
70.0±52.4
66 [28.25-90]
0.6
Days from procedure to discharge (days)
7.6±4.8
7 [3-10]
10.7±9.3
8 [3.5-13.5]
0.2
